Alphonse Ouédraogo

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Plasmodium Falciparum

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Alphonse Ouédraogo, Julie Nguyen Ngoc Pouplin, Mavuto Mukaka, Thoopmanee Kaendiao, Andrea Ruecker, Pascal Millet, Thibaut Vallet, Fabrice Ruiz, Sodiomon B Sirima, Walter R Taylor
Anti-infectivity efficacy and pharmacokinetics of WHO recommended single low-dose primaquine in children with acute Plasmodium falciparum in Burkina Faso: study protocol. Trials 25 (1) (2024)
Issa Nebie, Nirianne Marie Q Palacpac, Edith Christiane Bougouma, Amidou Diarra, Alphonse Ouédraogo, Flavia D'Alessio, Sophie Houard, Alfred B Tiono, Simon Cousens, Toshihiro Horii, Sodiomon Bienvenu Sirima
Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5-10-Year-Old Burkinabe Children Naturally Exposed to Malaria. Vaccines 12 (2) (2024)
Issa Nebie, Nirianne Marie Q Palacpac, Edith Christiane Bougouma, Amidou Diarra, Alphonse Ouédraogo, Flavia D'Alessio, Sophie Houard, Alfred B Tiono, Simon Cousens, Toshihiro Horii, Sodiomon Bienvenu Sirima
Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5-10-Year-Old Burkinabe Children Naturally Exposed to Malaria. Vaccines 12 (2) (2024)
Alphonse Ouédraogo, Julie Nguyen Ngoc Pouplin, Mavuto Mukaka, Thoopmanee Kaendiao, Andrea Ruecker, Pascal Millet, Thibaut Vallet, Fabrice Ruiz, Sodiomon B Sirima, Walter R Taylor
Anti-infectivity efficacy and pharmacokinetics of WHO recommended single low-dose primaquine in children with acute Plasmodium falciparum in Burkina Faso: study protocol. Trials 25 (1) (2024)